MedPath
HSA Approval

KAOMIX ORAL MIXTURE

SIN08787P

KAOMIX ORAL MIXTURE

KAOMIX ORAL MIXTURE

July 3, 1996

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantICM PHARMA PTE. LTD.
Licence HolderICM PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

A07BC30

combinations

Manufacturer Information

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Active Ingredients

SODIUM BICARBONATE

5% w/v

Sodium bicarbonate

KAOLIN LIGHT

20% w/v

Kaolin

MAGNESIUM CARBONATE LIGHT

5% w/v

Magnesium carbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KAOMIX ORAL MIXTURE - HSA Approval | MedPath